Natural Sciences Active Updated Jul 29, 2026
Protacs: drugs that destroy their target instead of blocking it
Protacs, a drug class first proposed in 2001, grab a disease-causing protein and drag it to the cell's own disposal system rather than just binding and blocking it, letting them act on proteins long considered undruggable. The first protac drug won approval this year, two decades after the idea began as a lab curiosity, and the arc will run as more protacs move toward patients.
The story so far
-
Jul 29, 2026 Latest
New Scientist reported the approval this year of the first protac drug, a class that destroys disease-causing proteins by tagging them for the cell's disposal system instead of simply blocking them, opening treatment options for proteins previously considered undruggable.
This story moves with the morning letter.
When this arc advances, the timeline above grows the same morning. One short, warm letter with the day's real progress in science, medicine and beyond. Free, every day.
Free forever, no spam. One click to unsubscribe, and we never sell your email.